Trieza Therapeutics, Inc. — Form D
Trieza Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-12-05. The offering totals $6.0M, of which $6.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-12-05
- Form: D
- Accession: 0001691194-16-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $6.0M
- Investors: 5
- Date of first sale: 2016-11-22
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-275662
Issuer
- Name: Trieza Therapeutics, Inc.
- CIK: 0001691194
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 1030 MASSACHUSETTS AVENUE, CAMBRIDGE, MA, 02138
- Phone: 617-588-4150
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Luke Evnin | Director | Watertown, MA |
| Daniel Hicklin | Director | Cambridge, MA |
| David Cordo | Executive Officer | Cambridge, MA |
| Daniel Hicklin | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More